Bionik Laboratories (BNKL) Stock Price, News & Analysis

Company Overview

Bionik Laboratories is a medical device company focused on the development and commercialization of robotic-based therapies for rehabilitation and mobility restoration. The company’s core products include the InMotion ARM and InMotion Hand systems, which provide targeted robotic-assisted therapy for upper limb rehabilitation in patients recovering from stroke, spinal cord injuries and other neurological disorders. Bionik leverages advanced software, sensors and machine learning to deliver personalized treatment protocols and track patient progress in real time.

Expanding beyond upper limb solutions, Bionik introduced the ARKE lower extremity exoskeleton to support gait training and balance recovery, as well as the REX Robotic Exoskeleton for upright mobility in individuals with severe lower limb disabilities. These devices are designed to restore functional independence and improve overall quality of life by enabling repetitive, high-intensity therapeutic movements that are difficult to achieve through traditional therapy alone. Integrating hardware, software and clinical data, Bionik’s platforms adapt dynamically to each user’s needs.

Bionik collaborates with rehabilitation centers, hospitals and research institutions to validate and refine its technologies, contributing to clinical research and publishing outcomes that demonstrate enhanced patient engagement and functional gains. Through strategic partnerships and ongoing innovation, the company aims to transform standard rehabilitation practices and expand access to advanced, data-driven therapeutic solutions for individuals with neurological impairments. By combining robotics expertise with medical insights, Bionik seeks to accelerate recovery pathways and deliver better long-term outcomes for patients worldwide.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 1 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BNKL Stock Analysis - Frequently Asked Questions

How do I buy shares of Bionik Laboratories?

Shares of BNKL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Bionik Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Bionik Laboratories investors own include Ashford Hospitality Trust (AHT), Assertio (ASRT), Peabody Energy (BTU), Co-Diagnostics (CODX), Adamis Pharmaceuticals (ADMP), PlayAGS (AGS) and Ardmore Shipping (ASC).

Company Calendar

• Today: 7/06/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:BNKL
• CIK: 1508381
• Web: www.bioniklabs.com
• Phone: (617) 926-4800
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.80 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A